Omalizumab treatment and outcomes in Chinese patients with chronic spontaneous urticaria, chronic inducible urticaria, or both

BACKGROUND: Chronic urticaria (CU) is a common skin disorder, which can be further divided into chronic spontaneous urticaria (CSU) and chronic inducible urticaria (CIndU). Omalizumab is effective and safe for difficult-to-treat CSU based on clinical trials. However, there are limited data comparing...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yudi, Yu, Miao, Huang, Xiaojie, Tu, Ping, Shi, Peikun, Maurer, Marcus, Zhao, Zuotao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7804987/
https://www.ncbi.nlm.nih.gov/pubmed/33510832
http://dx.doi.org/10.1016/j.waojou.2020.100501

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7804987/
https://www.ncbi.nlm.nih.gov/pubmed/33510832
http://dx.doi.org/10.1016/j.waojou.2020.100501

Ejemplares similares